Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Oct 6.
doi: 10.1111/bjh.70164. Online ahead of print.

Growth measurements in Ugandan children with sickle cell anaemia from a hydroxyurea (hydroxycarbamide) treatment trial relative to unaffected sibling controls

Dennis Kalibbala  1 , Vincent Mboizi  1 , Grace Nambatya  1 , Susan Murungi  1 , Joan Ashaba  1 , Catherine Nabaggala  1 , Lynnth Turyagyenda  2 , Deogratias Munube  3 , Phillip Kasirye  3   4 , Bill Wambaka  1 , Amiirah Mpungu  1 , John M Ssenkusu  5 , Ruth Namazzi  3 , Paul Bangirana  1   6 , Robert O Opoka  7 , Ezekiel Mupere  3 , Richard Idro  3 , Nancy S Green  8
Affiliations

Growth measurements in Ugandan children with sickle cell anaemia from a hydroxyurea (hydroxycarbamide) treatment trial relative to unaffected sibling controls

Dennis Kalibbala et al. Br J Haematol. .

Abstract

Children with sickle cell anaemia (SCA) in sub-Saharan Africa (SSA) frequently experience impaired growth. Hydroxyurea (hydroxycarbamide) improves growth in higher resourced countries, but its effects on growth and body composition have not been evaluated in SSA. In an open-label, single-arm, 30-month dose-escalated hydroxyurea trial in Ugandan children aged 3 to <10 years (N = 264, mean age 5.6 ± 1.7 years), participant anthropometrics were compared to non-SCA sibling controls using global age- and sex-normalized z-scores. Body composition was determined using bioelectrical impedance analysis (BIA), comparing their z-scores to those generated from the controls (N = 110). Prospectively, SCA growth parameters on hydroxyurea paralleled and correlated with haemoglobin levels but remained lower than controls for weight, height and body mass index for age. Notably, growth of the SCA participants enrolled at ages 3 to <5 years did not differ from controls; instead, all group differences were attributable to those enrolled at ages 5 to <10. Further analyses revealed that growth trajectories of SCA age-dependent weight and height improved from being significantly lower than controls at trial entry to similarity at completion. Fat-free mass improved, although it and the fat mass both remained lower than that of the controls. Findings suggest that hydroxyurea promotes healthier growth and may improve body composition in children with SCA in SSA; earlier treatment initiation had a greater impact.

Keywords: body composition; children; growth; hydroxyurea; sickle cell anaemia.

PubMed Disclaimer

References

REFERENCES

    1. Ndeezi G, Kiyaga C, Hernandez AG, Munube D, Howard TA, Ssewanyana I, et al. Burden of sickle cell trait and disease in the Uganda sickle surveillance study (US3): a cross‐sectional study. Lancet Glob Health. 2016;4(3):e195–e200.
    1. Al‐Saqladi AW, Cipolotti R, Fijnvandraat K, Brabin BJ. Growth and nutritional status of children with homozygous sickle cell disease. Ann Trop Paediatr. 2008;28(3):165–189. https://doi.org/10.1179/146532808X335624
    1. Mitchell MJ, Carpenter GJ, Crosby LE, Bishop CT, Hines J, Noll J. Growth status in children and adolescents with sickle cell disease. Pediatr Hematol Oncol. 2009;26(4):202–215. https://doi.org/10.1080/08880010902896882
    1. Nartey EB, Spector J, Adu‐Afarwuah S, Jones CL, Jackson A, Ohemeng A, et al. Nutritional perspectives on sickle cell disease in Africa: a systematic review. BMC Nutr. 2021;7(1):9. https://doi.org/10.1186/s40795‐021‐00410‐w
    1. Hyacinth HI, Gee BE, Hibbert JM. The role of nutrition in sickle cell disease. Nutr Metab Insights. 2010;3:57–67. https://doi.org/10.4137/NMI.S5048

LinkOut - more resources